Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Market Cap	1.52T +36.6%
Revenue (ttm)	139.80B +21.4%
Net Income	21.63B +13.2%
EPS	63.92 +13.2%
Shares Out	n/a
PE Ratio	70.16
Forward PE	60.96
Dividend	35.00 (0.78%)
Ex-Dividend Date	Feb 18, 2026

Volume	205,936
Average Volume	281,501
Open	4,474.30
Previous Close	4,469.20
Day's Range	4,440.70 - 4,535.00
52-Week Range	3,102.00 - 4,555.10
Beta	0.15
RSI	61.90
Earnings Date	May 22, 2026

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It als...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 17,059
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: TORNTPHARM

Financial Performance

In fiscal year 2026, Torrent Pharmaceuticals's revenue was 139.80 billion, an increase of 21.40% compared to the previous year's 115.16 billion. Earnings were 21.63 billion, an increase of 13.17%.